We are live on
!
Find out more
Solid Biosciences
SLDB
SLDB
150 hedge funds and large institutions have $717M invested in Solid Biosciences in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
183% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 12
96% more call options, than puts
Call options by funds: $2.2M | Put options by funds: $1.12M
56% more capital invested
Capital invested by funds: $459M → $717M (+$258M)
38% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 40
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
15% more funds holding
Funds holding: 130 → 150 (+20)
3.11% less ownership
Funds ownership: 104.45% → 101.34% (-3.1%)
Holders
150
Holders Change
+20
Holders Change %
+15.38%
% of All Funds
1.85%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
34
Increased
55
Reduced
40
Closed
12
Calls
$2.2M
Puts
$1.12M
Net Calls
+$1.08M
Net Calls Change
-$2.41M
Top Buyers
Top Sellers
| 1 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$5.42M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$5.24M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5.22M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.82M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.35M |
